MedPath

Low Dose Aspirin Studied With the AggreGuide

Completed
Conditions
Platelet Aggregation
Registration Number
NCT01603966
Lead Sponsor
Edward R. Teitel, M.D.
Brief Summary

This study is to determine whether the AggreGuide platelet aggregometer can discern the effect of low dose aspirin on subjects platelet aggregation using arachidonic acid as the agonist.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
13
Inclusion Criteria
  • adults
Exclusion Criteria
  • aspirin contraindications
  • anticoagulants
  • aspirin past week

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Aggredyne, Inc.

🇺🇸

Houston, Texas, United States

Aggredyne, Inc.
🇺🇸Houston, Texas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.